XML 32 R17.htm IDEA: XBRL DOCUMENT v3.25.3
Financial Assets and Liabilities
12 Months Ended
Oct. 31, 2025
Financial Assets And Liabilities [Abstract]  
Financial Assets and Liabilities Financial Assets and Liabilities
Cash Equivalents and Short-term Investments
As of October 31, 2025, the balances of our cash equivalents and short-term investments are as follows:
Amortized CostGross
Unrealized
Gains
Gross
Unrealized
Losses Less Than 12 Continuous Months
Gross
Unrealized
Losses 12 Continuous Months or Longer
Estimated
Fair Value
(1)
 (in thousands)
Cash equivalents:
Money market funds$52,978 $— $— $— $52,978 
Total:$52,978 $— $— $— $52,978 
Short-term investments:
U.S. Treasury, agency & T-bills$6,661 $19 $— $— $6,680 
Municipal bonds22,004 61 — — 22,065 
Corporate debt securities43,878 139 (18)— 43,999 
Other185 — — — 185 
Total:$72,728 $219 $(18)$— $72,929 
(1)See Note 9. Fair Value Measurements for further discussion on fair values.
Our short-term investment portfolio includes both corporate and government debt securities that have a maximum maturity of three years. The longer the duration of these securities, the more susceptible they are to changes in market interest rates and bond yields. As yields increase, those securities with a lower yield-at-cost show a mark-to-market unrealized loss. Most of our unrealized losses are due to changes in market interest rates, and bond yields. We believe that we have the ability to realize the full value of all of these investments upon maturity. As of October 31, 2025, our investments that were in a continuous loss position of 12 months or more, as well as the unrealized losses on those investments, were immaterial.
The contractual maturities of our available-for-sale debt securities as of October 31, 2025 are as follows:
Amortized CostFair Value
(in thousands)
Less than 1 year$26,944 $27,014 
1-5 years45,784 45,915 
Total$72,728 $72,929 
As of October 31, 2024, the balances of our cash equivalents and short-term investments are as follows:
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses Less Than 12 Continuous Months
Gross
Unrealized
Losses 12 Continuous Months or Longer
Estimated
Fair Value
(1)
 (in thousands)
Cash equivalents:
Money market funds$869,972 $— $— $— $869,972 
U.S. Treasury, agency & T-bills7,984 — — 7,985 
Total:$877,956 $$— $— $877,957 
Short-term investments:
U.S. Treasury, agency & T-bills$19,411 $44 $(6)$— $19,449 
Corporate debt securities105,024 349 (115)(2)105,256 
Asset-backed securities29,061 130 (7)(20)29,164 
Total:$153,496 $523 $(128)$(22)$153,869 
(1)See Note 9. Fair Value Measurements for further discussion on fair values.
Restricted cash
We include amounts generally described as restricted cash in cash and cash equivalents when reconciling beginning-of-period and end-of-period total amounts shown in the consolidated statements of cash flows. Restricted cash is primarily associated with deposits for office leases and employee loan programs.
The following table provides a reconciliation of cash, cash equivalents and restricted cash included in the consolidated balance sheets and the consolidated statements of cash flows:
As of October 31,
20252024
(in thousands)
Cash and cash equivalents$2,888,030 $3,896,532 
Restricted cash included in prepaid and other current assets4,680 1,529 
Restricted cash included in other long-term assets1,011 668 
Cash, cash equivalents and restricted cash$2,893,721 $3,898,729 
Non-marketable equity securities
Our portfolio of non-marketable equity securities consists of strategic investments in privately held companies. During the first quarter of fiscal 2024, we completed the sale of certain strategic investments in privately-held companies. The gain recognized from the sales was $55.1 million and included in other income (expense), net, in our consolidated statements of income. There were no material impairments of non-marketable equity securities in fiscal 2025, 2024, and 2023.
Derivatives
We recognize derivative instruments as either assets or liabilities in the consolidated balance sheets at fair value and provide qualitative and quantitative disclosures about such derivatives. We operate internationally and are exposed to potentially adverse movements in foreign currency exchange and interest rates. We enter into hedges in the form of foreign currency forward contracts to reduce our exposure to foreign currency rate changes on non-functional currency denominated forecasted transactions and balance sheet positions including: (1) certain assets and liabilities, (2) shipments forecasted to occur within approximately one month, (3) future billings and revenue on previously shipped orders, and (4) certain future intercompany invoices denominated in foreign currencies.
The majority of the forward contracts are short-term with maturity of up to 30 months at inception. We do not use foreign currency forward contracts for speculative or trading purposes. We enter into foreign exchange forward contracts with high credit quality financial institutions that are rated "A" or above and to date have not experienced nonperformance by counterparties. In addition, we mitigate credit risk in derivative transactions by permitting net settlement of transactions with the same counterparty and anticipate continued performance by all counterparties to such agreements.
The assets or liabilities associated with the forward contracts are recorded at fair value in other current assets or accrued liabilities in the consolidated balance sheets. The accounting for gains and losses resulting from changes in fair value depends on the use of the foreign currency forward contract and whether it is designated and qualifies for hedge accounting. The cash flow impact upon settlement of the derivative contracts is included in net cash provided by operating activities in the consolidated statements of cash flows.
Additionally, in order to manage interest rate exposure related to anticipated debt transactions, in the first quarter of fiscal 2025, we entered into treasury rate lock agreements to hedge against unfavorable interest rate changes. The accounting for gains and losses resulting from changes in fair value depends on whether these are designated and qualify for hedge accounting. The assets or liabilities associated with these derivatives are recorded at fair value in other current assets or accrued liabilities in the consolidated balance sheets. The cash flow impact upon settlement of these derivative contracts is included in net cash used in operating activities in the consolidated statements of cash flows.
Cash Flow Hedging Activities
Certain foreign exchange forward contracts are designated and qualify as cash flow hedges. These contracts have durations of up to 30 months or less. Certain forward contracts are rolled over periodically to capture the full length of exposure to our foreign currency risk, which can be up to three years. To receive hedge accounting treatment, all hedging relationships are formally documented at the inception of the hedge, and the hedges must be highly effective in offsetting changes to future cash flows on the hedged transactions. The related gains or losses resulting from changes in fair value of these hedges is initially reported, net of tax, as a component of other comprehensive income (loss) (OCI) in stockholders’ equity and reclassified into revenue or operating expenses, as appropriate, at the time the hedged transactions affect earnings. We expect a majority of the hedge balance in OCI to be reclassified to the statements of income within the next 12 months.
We did not record any gains or losses related to discontinuation of foreign exchange forward contracts cash flow hedges for fiscal years 2025, 2024 and 2023.
During the first quarter of fiscal 2025, we entered into 6-month interest rate hedge contracts (the 2025 Rate Lock Agreements) with notional value of $2.0 billion to lock the benchmark interest rate prior to expected debt issuances with 10-year and 30-year terms. The objective of the 2025 Rate Lock Agreements was to hedge the risk associated with the variability in interest rates due to the changes in the benchmark rate leading up to the closing of the intended financing on the notional amount being hedged. To receive hedge accounting treatment, the hedging relationships are formally documented at the inception of the hedge, and the hedges must be highly effective in offsetting changes to future cash flows on the hedged transactions. These derivatives are designated as cash flow hedges with unrealized gains and losses deferred in OCI. The 2025 Rate Lock Agreements terminated and settled in the second quarter of fiscal 2025, and we recorded the fair value of $121.6 million as a loss within OCI. The unrealized loss of $121.6 million is being amortized to interest expense over the life of the related debt. We expect $7.0 million of the unrealized loss to be amortized to interest expense over the next 12 months. As of October 31, 2025, the unamortized portion of the fair value of the 2025 Rate Lock Agreements was $117.0 million. We had no interest rate hedge contracts outstanding as of October 31, 2025.
During the second quarter of fiscal 2025, we entered into a deferred payment agreement with the counterparty bank to defer the cash settlement of 2025 Rate Lock Agreements over a period of 5.5 years with installments due semi-annually. The implied interest rate is 3.45%. This liability is recognized in our consolidated balance sheets as short-term debt for the portion due within the next 12 months and as long-term debt for the remaining portion. There were no debt covenants applicable to the deferred payment agreement.
Non-designated Hedging Activities
Our foreign exchange forward contracts that are used to hedge non-functional currency denominated balance sheet assets and liabilities are not designated as hedging instruments. Accordingly, any gains or losses from changes in the fair value of the forward contracts are recorded in other income (expense), net. The gains and losses on these forward contracts generally offset the gains and losses associated with the underlying assets and liabilities, which are also recorded in other income (expense), net. The duration of the forward contracts for hedging our balance sheet exposure is approximately one month.
We also have certain foreign exchange forward contracts for hedging certain international revenues and expenses that are not designated as hedging instruments. Accordingly, any gains or losses from changes in the fair value of these forward contracts are recorded in other income (expense), net. The gains and losses on these forward contracts generally offset the gains and losses associated with the foreign currency in operating income. The duration of these forward contracts is usually less than one year. The overall goal of our hedging program is to minimize the impact of currency fluctuations on the net income over the fiscal year.
The effects of the non-designated foreign currency derivative instruments in the consolidated statements of income are summarized as follows: 
 
Year Ended October 31,
 202520242023
 (in thousands)
Gains (losses) recorded in other income (expense), net$(5,492)$(307)$(5,899)
The notional amounts in the table below for foreign currency derivative instruments provide one measure of the transaction volume outstanding:
As of October 31,
20252024
 (in thousands)
Total gross notional amounts$1,587,863 $1,686,341 
Net fair value$(1,234)$1,819 
Our exposure to the market gains or losses will vary over time as a function of currency exchange rates. The amounts ultimately realized upon settlement of these financial instruments, together with the gains and losses on the underlying exposures, will depend on actual market conditions during the remaining life of the instruments.
The following table represents the consolidated balance sheets location and amount of foreign currency derivative instrument fair values segregated between designated and non-designated hedge instruments: 
Fair values of
derivative instruments
designated as
hedging instruments
Fair values of
derivative instruments
not designated as
hedging instruments
 (in thousands)
Balance at October 31, 2025
Other current assets$8,598 $265 
Accrued liabilities$9,504 $593 
Balance at October 31, 2024
Other current assets$8,839 $12 
Accrued liabilities$6,918 $114 
The following table represents the location of the amount of gains and losses on derivative instrument fair values for designated hedge instruments, net of tax in the consolidated statements of income:
Location of gains (losses)
recognized in OCI on
derivatives
Amount of gains (losses)
recognized in 
OCI on
derivatives
(effective portion)
Location of gains (losses)
reclassified 
from OCI
Amount of
gains (losses)
reclassified 
from OCI
(effective 
portion)
 (in thousands)
Fiscal year ended October 31, 2025
Foreign exchange contractsRevenue$20,434 Revenue$3,155 
Foreign exchange contractsOperating expenses(7,292)Operating expenses(3,320)
Interest rate contractsInterest expense(93,216)
Interest expense
(3,551)
Total$(80,074)$(3,716)
Fiscal year ended October 31, 2024
Foreign exchange contractsRevenue$3,940 Revenue$3,089 
Foreign exchange contractsOperating expenses5,685 Operating expenses112 
Total$9,625 $3,201 
Fiscal year ended October 31, 2023
Foreign exchange contractsRevenue$8,390 Revenue$(9,942)
Foreign exchange contractsOperating expenses16,596 Operating expenses(15,334)
Total$24,986 $(25,276)